First Hawaiian Bank’s Alaunos Therapeutics TCRT Stock Holding History

First Hawaiian Bank’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-693	Closed	-$333K	–	1888
2018 Q3	$333K	Buy	+693	New	+$297K	0.02%	592

Other funds holding TCRT

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

First Hawaiian Bank's TCRT Position: Q4 2018 in Review

First Hawaiian Bank sold out of Alaunos Therapeutics (TCRT) in Q4 2018, closing a stake of 693 shares — an estimated $333K sold.

First Hawaiian Bank first reported a position in TCRT in Q3 2018 and held it in 1 quarter. The position peaked at $333K in Q3 2018. 137 funds tracked by Wall St. Rank hold TCRT as of Q4 2018.

First Hawaiian Bank reported no remaining Alaunos Therapeutics position as of Q4 2018 after selling out during the quarter.
First Hawaiian Bank sold 693 Alaunos Therapeutics shares in Q4 2018, an estimated $333K.
First Hawaiian Bank first reported a position in Alaunos Therapeutics in Q3 2018 and held it in 1 quarter.
First Hawaiian Bank's Alaunos Therapeutics position peaked at $333K in Q3 2018.
137 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2018.

Based on First Hawaiian Bank's 13F filing for Q4 2018, filed 11 Jan 2019.